Piccolo Medical, Inc., a San Francisco, CA-based developer of catheter navigation technology, closed a $5.5M Series B financing.
The round was led by Event Capital Strategies. Chris Yamamoto, Managing Partner of Event Capital Strategies, joined Piccolo’s Board of Directors alongside Drs. Mark Healy and Dan Burnett, the founder of the Theranova medical device incubator.
The company intends to use the funds for the further development and commercialization of its catheter guidance technology, including the next-generation SmartPICC® cathether tip location and navigation system that received 510(k) approval from the FDA in January 2021.
Led by CEO Augustus (Augie) Shanahan, Piccolo Medical was spun out of the Theranova medical device incubator in San Francisco, CA. It has been funded by private investors as well as Phase I and II grant awards from the National Institute of Health’s National Institute of Aging. Piccolo received 510(k) clearance for the SmartPICC® System in 2021.
FinSMEs
02/10/2023